Print

NCHECR-AE1

A randomized, placebo-controlled, double blind, phase I/IIa clinical trial to evaluate the safety and immunogenicity of a candidate prophylactic DNA prime-rFPV boost HIV vaccination strategy

Trial Details:

I/II Completed
The National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales July 01, 2007
rFPV-HIV-AE,pHIS-HIV-AE Pox Gag, Pol, Tat, Rev, Env A&E; DNA Gag,Pol, Tat, Rev, Env A&E
pHIS-HIV-AE DNA
rFPV-HIV-AE Viral Vector - Pox
Thailand 8
NCT00476749
http://www.med.unsw.edu.au/nchecr http://clinicaltrials.gov/ct2/show/NCT00333424?term=NCHECR-AE1&rank=1